// App-Quantinova.ai

e12535 : Automated immunostaining-free prediction of breast carcinoma ER and PR status, Ki67 count, patient therapy stratification index and quantification of prognostic quiescence burden in TNBC from pretreatment H&E stained histopathology images in breast cancer.

Researchers

Presenter

  • Tathagata Dasgupta

Principal Investigators

  • Satabhisa Mukhopadhyay

  • Nicolas M Orsi

  • Michele Cummings

  • Angelene Berwick

Medical Centers

  • 4D Path Inc., Newton, MA

  • St James Hospital, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

  • Triple-negative breast cancer

Biomarkers

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved